These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6291446)

  • 1. [Metabolism of insulin and immunoreactive insulin-like substances (proinsulin, HWIRI) in vivo in man].
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    Ann Endocrinol (Paris); 1982; 43(1):15-21. PubMed ID: 6291446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portal, hepatic and peripheral insulin immunoreactive substances before and after removal of an insulinoma.
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    J Endocrinol Invest; 1982; 5(5):315-21. PubMed ID: 6296220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of exogenous hyperinsulinemia on proinsulin secretion in normal man, obese subjects, and patients with insulinoma.
    Koivisto VA; Yki-Järvinen H; Hartling SG; Pelkonen R
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1117-20. PubMed ID: 3020076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulinoma with low circulating insulin levels: the diagnostic value of proinsulin measurements.
    Alsever RN; Roberts JP; Gerber JG; Mako ME; Rubenstein AH
    Ann Intern Med; 1975 Mar; 82(3):347-50. PubMed ID: 163611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and localization of an insulinoma with inappropriate hypoglycemia in relation to the level of immunoreactive insulin using gel chromatographic separation.
    Kakita K; Horino M
    Exp Clin Endocrinol; 1985 Apr; 85(2):167-75. PubMed ID: 2990974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma insulin response to various secretagogues in insulinoma.
    Ohneda A; Kobayashi T; Nihei J
    Tohoku J Exp Med; 1982 Apr; 136(4):447-57. PubMed ID: 6285549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of liver and kidney on high molecular weight immunoreactive insulin (HWIRI), proinsulin (PI) and insulin (I) in man.
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    Horm Metab Res; 1981 Oct; 13(10):583-4. PubMed ID: 7028592
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid assay of insulin in portosplenic blood for insulinoma.
    Yao CZ; Zeng XJ; Niu ZP
    Chin Med J (Engl); 1984 Jan; 97(1):57-60. PubMed ID: 6329612
    [No Abstract]   [Full Text] [Related]  

  • 9. Acinar-islet cell carcinoma presenting as insulinoma.
    Shimoike T; Goto M; Nakano I; Sato T; Migita Y; Ito T; Yanase T; Sezai S; Suzuki T; Nawata H
    J Gastroenterol; 1997 Dec; 32(6):830-5. PubMed ID: 9430026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactive insulin assay in insulinoma.
    Zeng XJ; Yao CZ; Zhong SX; Zhang JX; Zhu Y; Wu CY
    Chin Med J (Engl); 1983 Aug; 96(8):575-82. PubMed ID: 6315315
    [No Abstract]   [Full Text] [Related]  

  • 11. Degradation during storage of high molecular weight immunoreactive insulin (HWIRI) and proinsulin (PLC) in extracts of Benign insulinomas and adjacent pancreatic tissue.
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    Horm Metab Res; 1981 Sep; 13(9):528-9. PubMed ID: 6271661
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterogeneity of circulating insulin and proinsulin in man.
    Horwitz DL; Rubenstein AH
    Isr J Med Sci; 1974 Oct; 10(10):1201-11. PubMed ID: 4373412
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insulinoma with hyperproinsulinemia: a two cases report].
    Gury H; Rio F; Neamtu D; Boivin S
    Ann Endocrinol (Paris); 2002 Jun; 63(3):240-2. PubMed ID: 12193882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of high molecular weight insulins in insulinoma patients.
    Permutt M; Biesbroeck J; Chyn R
    J Clin Endocrinol Metab; 1977 Mar; 44(3):536-44. PubMed ID: 190261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monitoring effect of rapid determination of portal and splenic venous blood insulin in surgical operation for insulinoma].
    Yao CZ
    Zhonghua Yi Xue Za Zhi; 1983 Nov; 63(11):667-9. PubMed ID: 6326973
    [No Abstract]   [Full Text] [Related]  

  • 16. Mithramycin for hypoglycemia in malignant insulinoma.
    Kiang DT; Frenning DH; Bauer GE
    N Engl J Med; 1978 Jul; 299(3):134-5. PubMed ID: 207984
    [No Abstract]   [Full Text] [Related]  

  • 17. 28-hour profiles of blood glucose (BG), plasma immunoreactive insulin (IRI) and IRI/BG ratio in four insulinomas.
    Villaume C; Beck B; Dollet JM; Pointel JP; Drouin P; Debry G
    Ann Endocrinol (Paris); 1984; 45(3):155-60. PubMed ID: 6098216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of insulinomas. Determination of insulin, C-peptide and proinsulin in blood to differentiate between endogenous and exogenous hyperinsulinism].
    Hanssen KF; Torjesen PA; Heding LG
    Tidsskr Nor Laegeforen; 1981 Dec; 101(34-36):1957-60. PubMed ID: 6280336
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypoglycemic Syndrome without Hyperinsulinemia. A Diagnostic Challenge.
    Pérez-Pevida B; Idoate MÁ; Fernández-Landázuri S; Varo N; Escalada J
    Endocr Pathol; 2016 Mar; 27(1):50-4. PubMed ID: 26801953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unresponsiveness of insulinoma cells to secretin: significance of the secretin test in patients with insulinoma.
    Imamura M; Hattori Y; Nishida O; Honda T; Shimada Y; Miyahara T; Wagata T; Baba N; Tobe T
    Pancreas; 1990 Jul; 5(4):467-73. PubMed ID: 2166285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.